Plasma levels of platinum-induced fatty acid [16:4n-3] do not affect response to platinum-based chemotherapy: A pilot study in non-small cell lung cancer patients.

CONCLUSIONS: This first of its kind study that evaluated plasma 16:4(n-3) in NSCLC patients showed that 16:4 (n-3) was elevated during FO supplementation, independent of fish oil supplementation or platinum-based chemotherapy.
PMID: 33183547 [PubMed - in process]

Source: Clinical Lung Cancer - November 17, 2020 Category: Cancer & Oncology Authors: van der Meij BS, Teleni L, Stanislaus AE, Murphy RA, Robinson L, Damaraju VL, Chu Q, Sawyer MB, Mazurak V Tags: Clin Nutr ESPEN Source Type: research